Methods of T Cell Depletion Trial (MoTD)

Clinical trial NCT04888741 · RECRUITING

Trial details

NCT number: NCT04888741
Sponsor: University of Birmingham
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes Non Hodgkin Lymphoma Hodgkin Lymphoma Multiple Myeloma Chronic Myelogenous Leukemia Myelofibrosis

Start date: 2021-02-22
Primary completion: 2027-08-23
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.